Related Experiment Videos
The management of subclinical hyperthyroidism by thyroid specialists
Michael T McDermott1, Whitney W Woodmansee, Bryan R Haugen
1Division of Endocrinology, Metabolism & Diabetes, and Division of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado 80010, USA. Michael.mcdermott@uchsc.edu
Thyroid : Official Journal of the American Thyroid Association
|January 31, 2004
Summary
Management of subclinical hyperthyroidism lacks guidelines. Expert opinions from the American Thyroid Association (ATA) suggest further evaluation for most cases and observation for younger patients, but treatment for older patients with undetectable TSH levels.
Area of Science:
- Endocrinology
- Thyroidology
- Clinical Medicine
Background:
- Subclinical hyperthyroidism is common, yet evidence-based management guidelines are lacking.
- Expert consensus is needed to guide clinical practice for this condition.
Purpose of the Study:
- To survey American Thyroid Association (ATA) members' opinions on managing subclinical hyperthyroidism.
- To identify expert recommendations for diagnostic workup and treatment strategies.
Main Methods:
- A case-based mail survey was sent to 300 ATA members.
- 185 members (62%) responded, evaluating four hypothetical patient cases.
- Responses were analyzed to determine consensus on diagnostic tests and treatment approaches.
Main Results:
- Most respondents recommended further evaluation, including radioactive iodine uptake, thyroid scans, and antibody testing.
- Observation was favored for younger patients, regardless of TSH levels.
- Treatment was favored for older patients with undetectable TSH, with specific therapy choices based on etiology (Graves' disease vs. toxic nodular disease).
Conclusions:
- Expert opinions highlight a preference for observation in younger patients with subclinical hyperthyroidism.
- Management of older patients, particularly those with undetectable TSH, leans towards active treatment.
- Survey results offer practical guidance in the absence of formal evidence-based guidelines for subclinical hyperthyroidism.